Saarland University,
Starterzentrum, Building A1 1,
66123, Saarbruecken
Germany
Didn't we got you connected? Please note the following magic buttons:
Want to place your Ads or News on DIGITAL HEALTH NEWS?
DIGITAL HEALTH NEWS is the first European digital health news portal and one of the most visited sites on the Internet for digital health decision-makers, professionals and stakeholders looking for the latest digital health breaking news.
We have the solutions that meet your ambitious marketing objectives. We offer flexible and price-worthy advertising opportunities for you to take advantage of. These include:
- Skyscraper Banner, 160px / 600px (left-top, left-bottom)
- Medium Rectangle Banner, 300px / 250px (right-top, medium and right-bottom)
- Newsletter Medium Rectangle Banner, 300px / 250px
DIGITAL HEALTH NEWS is a first read for European/International digital health professionals, decision makers and stakeholders. Our audience is represented by: digital health Industry and Hospital IT - 60%; Research - 30%; Media / Press / Blogosphere - 10%.
The strong, innovative capabilities of DIGITAL HEALTH NEWS can support your advertising, news promotion and news distribution campaigns. You will reach your objectives and an unique audience of top digital health professionals, stakeholders, key players and decision makers.
Most Popular Now
The Future of Medicine is Data
At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...
Study Surveys Landscape of Apps Built on…
A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...
New Computer Program 'Learns' to Identif…
Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...
Applications Open for SpinLab Accelerato…
The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...
Bayer to Accelerate Drug Discovery with …
Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...
Allscripts Announces Corporate Name Chan…
Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...
220M€ Investment in Testing and Experime…
To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...
AI Tool Developed to Predict Risk of Lun…
Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...
Artificial Nerve Cells - Almost Like Bio…
Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...
Bayer Acquires Blackford Analysis Ltd. B…
Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...
For Shared Decision-Making, Telemedicine…
Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...
Veradigm Announces Strategic Investment …
Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...